The full seven-pillar assessment on one biological.
The complete Quadros Bio methodology.
QBIView Standard scores one product or company independently across all seven readiness layers, across seven readiness pillars, and closes with a confidence-interval analysis and an expert narrative that names the risks and the unknowns explicitly. You receive a written report and a debrief call.
Page 1 of a QBIView Standard report (sample). The full report runs thirteen pages.
7
readiness pillars, each scored independently
13
pages in the sample assessment report
Best for
When Standard fits
- →Investors doing serious diligence on a candidate company
- →Founders preparing for a Series A or strategic round
- →Strategics evaluating a technology for licensing or partnership
- →Companies stress-testing their own evidence package before approaching investors
Deliverables
Report contents
- →Full seven-pillar assessment, each layer scored independently with rationale
- →Uncertainty interval or stated uncertainty model where applicable
- →Identified red flags and how they cluster across layers
- →Recommended actions for closing the most important evidence gaps
- →A written expert report and a debrief call with the lead scientist
The seven readiness pillars
Inside the report
A structured view of the gaps likely to require further diligence.
QBIView Standard scores a company across all seven readiness pillars, and closes with a confidence-interval analysis and a written expert narrative. The report opens with a one-page dashboard and then works through each pillar in depth; the current sample assessment runs thirteen pages.
Investment readiness score
A 0 to 100 score with its confidence range, placed on the four-tier investment structure, from Tier I conviction to Tier IV not yet investable.
Claimed vs evidence-verified
Your claimed score alongside the evidence-verified score, so the gap between what is asserted and what is evidenced today is explicit.
Critical blockers
Any hard blocker that caps the result regardless of the number, named plainly, with the reason and where to resolve it.
Seven-pillar profile
Every pillar scored on a five-point scale with a status, shown as both a table and a radar.
Per-pillar deep-dives
A written expert analysis of each pillar: the real strength, the principal gap, and the specific evidence reviewed.
Priority gaps and strengths
The bottlenecks to close first, and the levers already in your favour, each scored.
How to read the result
What the score means and what it does not: what an informed investor can defensibly conclude today, not a prediction of financial return.
A full sample report is available under NDA on request. The QBIView methodology itself stays proprietary.
The process
How an assessment runs.
01
Scoping
Confirm the company, the assessment scope, the regulatory geography, and the timeline. NDA exchanged if not already in place.
02
Materials
Receive pitch deck, technical dossier, IP materials, trial data, regulatory submissions, and any other relevant documents.
03
Assessment
Apply the seven-pillar framework, with subject-matter specialists from the Expert Network as the technology requires.
04
Report
The written QBIView Standard report is delivered with a debrief call, and an optional follow-up to support gap closure.
What it costs
One assessment. Two ways to run it.
Every option below is the same seventy-question instrument scored against the same seven layers. What changes is whether you work through it alone or with the scientist who signs the report, and how many you buy at once.
01
Standard assessment, unsupervised
CAD 120 per assessment
The full seventy-question instrument, completed online by the submitting organisation. Scored across the seven QBIView layers and returned as a report with a Go, Conditional or No-Go verdict.
Best for: Founders stress-testing their own science, investors triaging a deal, researchers exploring commercialization.
02
Standard assessment, supervised
CAD 499 per assessment
The same seventy questions, worked through with Dr. Patrícia Dörr de Quadros. Includes a two-hour meeting and consultation, and the report is written and signed by her.
Best for: Companies preparing for fundraising or partnership, and anyone who wants the questions interpreted rather than answered alone.
03
Twelve assessments
CAD 1,152 · 20 per cent off · CAD 96 each
One assessment a month across a portfolio or a product line. Paid in full at registration, then drawn down as you need them.
Best for: Investors and corporates running a pipeline rather than a single decision.
04
Twenty-four assessments
CAD 2,016 · 30 per cent off · CAD 84 each
Two assessments a month. Paid in full at registration, then drawn down as you need them.
Best for: Funds and acquirers assessing continuously.
Confidential by default. Not sold. Not published. Not shared without permission.
Next step
Put one biological through the full assessment.
Every option can be bought now. Prices are in Canadian dollars, with HST added at checkout where it applies. Questions before you buy: we respond within two business days.